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Results. The patients mean age was 50.7 ± 0.05 years, disease duration - 150 ± 0.05(2-504) 
months. Endothelial dysfunction was found in 9(45.0%) cases from the general group. 
Hypertension was found in 6(67.0%) and 8(73.0%), dyslipidemia 8(87.0%) and 10(90.0%), 
diabetes mellitus 3(33.0%) and 3(27.0%), smoking 1 (11.0%) and 1(9.0%), family history 2 
(22.0%) and 4(36.0%) in the group with and without endothelial dysfunction, respectively. BMI 
deviation was more relevant in the group without endothelial dysfunction - 8(72.7%) vs 4 
(44.4%) in patients with endothelial dysfunction. The level of CRP in women with dysfunctional 
endothelium was noted in 10(91.0%) cases vs 8(89.0%). Pathological API was present in 5 
(55.5%) of women with ED vs 4(36.3%) in subgroup without endothelial dysfunction. Analyzing 
the values obtained by ABI and TIM, we observed the predominance of abnormal data in the 
endothelial dysfunction subgroup.  
Conclusions. Endothelial dysfunction detected by flow-mediated dilatation using Doppler 
method suggests the high risk of cardiovascular events in patients with autoimmune systemic 
diseases.  
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Introduction. Sleep apnea (SA) is a major public health problem, with 5% prevalence of the 
active population aged between 30 and 60 years - 2% females and 4% males with severe 
cardiovascular, pulmonary, neurological and metabolic consequences. SA is found in 30% of 
hypertensive persons, in 19-20% of patients with myocardial infarction history; in 18 - 42% 
cases patients have cardiac arrhythmias: sleep association with marked sinus arrhythmias (93%), 
extreme sinusal bradycardias (40%), asistolias (33%), atrioventricular blocks (13%), ventricular 
arrhythmias (66%) and TV (13%), and ventricular extrasystoles (40%). Approximately 80% of 
patients with obstructive sleep apnea syndrome are overweight or obese. 
Aim of the study. Study of cardiac pathology in patients with sleep apnea. 
Materials and methods. In the study, 39 patients with sleep apnea were admitted to the 
Cardiology Institute in January-December 2017 with various cardiac pathologies, 71.8% men, 
28.2% women, the ratio being 2.5: 1, with an average age 53 ± 4 years. 
Results. Predominant risk factors in SA patients were: smoking (53.8%), obesity (74.4%), 
dyslipidemia (43.6%), diabetes mellitus (17.9%). Associated SA cardiac pathologies were meat 
in 82.6%, angina pectoris (AP) in 64.1%, MI (23.1%), stroke (7.7%), heart failure(NYHA) of 
different degree (74.4%), pulmonary hypertension (38.5%) and left ventricular hypertrophy  
(69.2%). Common ECG complications: arrhythmias in 100% (atrial fibrillation (33.3%), 
supraventricular extrasistoles (41%), ventricular extrasistoles (33.3%) and cardiac blocks in 
10.3%. Clinical manifestations were present by: snoring (94.9%), nicturia (61.5%), sleep 
fragmentation (59.0%), sleep stifling (43.6%), and daytime somnolence (33.3), and morning 
headache (28.2%), memory impairment in 20.5%. According to the SA classification according 
to the apnea-hipopnee index was: mild in 20.5%, medium in 23.1% and severe in 46.2%.  
Conclusions. In patients with sleep apnea, worsening of pre-existing cardiovascular pathologies 
with the development of major cardiac events, rhythm disturbances and conductibility which 
negatively influenced the progression and prognosis of these patients was diagnosed.  
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Introduction. In the last years, the global prevalence of the moderate-severe renal dysfunction 
has gradually increased to an epidemic state. The risk of chronic kidney disease occurrence in 
heart failure (HF) is not well established, but kidney dysfunction is very often encountered in HF 
patients and is associated with a poor prognosis. Thyroid hormone, also, has been identified as a 
risk factor for the heart disease progression and development. 
Aim of the study. To investigate whether thyroid function is associated with chronic kidney 
disease in heart failure patients. 
Materials and methods. This observational cohort study included 25 patients with reduced 
ejection fraction heart failure CKD. Routine biochemistry, including Cysteine C, thyroid 
stimulating hormone(TSH) and proteinuria were measured. Glomerular filtration rate (GFR) was 
estimated by the CKD-EPI CYSTETIN C based formula adjusted for Body Surface Area. We 
divided patients into two groups according to estimated GFR: ≥60ml/min (CKD stages I-II 
KDOQI); and <60ml/min(CKD stages III-V KDOQI). 
Results. Among 26 adult participants, 15 had moderate-to-severe decrease in eGFR<60 ml/min 
with a mean TSH level of 7.4±3.28 UN/ml(p<0.05); Cystetine C of 1.15±0.07 mg/L; mean 
ejection fraction (EF) of 43.4±2.84% level; uric acid level 446.2±81.27mmol/L; total cholesterol 
– 7.95±3.37 mmol/L; triglycerides 2.19 mmol/L and 0.12 g/l proteins in urine. 11 subjects had 
elevated, normal or mild decrease in eGFR≥60 ml/min; a mean TSH level of 2.2±0.65 UN/ml 
(p<0.01); Cystetine C of 1.74±0.13 mg/L; mean ejection fraction(EF) of 42±2.77%; uric acid 
level 235.5±113.5 mmol/L total cholesterol – 7.95±3.37 mmol/L; triglycerides 2.19 mmol/L, and 
0.07 g/l proteins in urine. Compared with participants with an estimated GFR ≥60 ml/min, those 
with estimated GFR <60 ml/min had an increased rate of subclinical primary hypothyroidism, 
higher levels of uric acid, total cholesterol and triglycerides. 
Conclusions. Our results suggest that subclinical hypothyroidism is associated not only with 
heart failure but also with CKD, and may be considered as a novel risk factor of reduced renal 
function. Further studies are needed to better understand the causal implications of 
hypothyroidism in CKD patients.  
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Introduction. Statins are a class of lipid-lowering medications, also known as HMG-CoA 
reductase inhibitors. They are considered one of the most popular prescribed agents worldwide 
for treatment of hypercholesterolemia. Statins are effective drugs to reduce cardiovascular events 
